NVN Liquidation, Inc. 6LUA.F Stock
NVN Liquidation, Inc. Price Chart
NVN Liquidation, Inc. 6LUA.F Financial and Trading Overview
| NVN Liquidation, Inc. stock price | 0.0010 EUR |
| Previous Close | 0.72 EUR |
| Open | 0.7 EUR |
| Bid | 0.72 EUR x N/A |
| Ask | 0.74 EUR x N/A |
| Day's Range | 0.7 - 0.7 EUR |
| 52 Week Range | 0.7 - 2.97 EUR |
| Volume | 4.2K EUR |
| Avg. Volume | 128 EUR |
| Market Cap | 19.51M EUR |
| Beta (5Y Monthly) | 0.161267 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.18 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 41.5 EUR |
6LUA.F Valuation Measures
| Enterprise Value | 43.98M EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.5186567 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.78275627 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.765 |
| Enterprise Value/EBITDA | -1.215 |
Trading Information
NVN Liquidation, Inc. Stock Price History
| Beta (5Y Monthly) | 0.161267 |
| 52-Week Change | -67.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.97 EUR |
| 52 Week Low | 0.7 EUR |
| 50-Day Moving Average | 1.07 EUR |
| 200-Day Moving Average | 1.31 EUR |
6LUA.F Share Statistics
| Avg. Volume (3 month) | 128 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 28.02M |
| Float | 25.51M |
| Short Ratio | N/A |
| % Held by Insiders | 0.45% |
| % Held by Institutions | 6.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -128.61% |
| Operating Margin (ttm) | -159.12% |
| Gross Margin | 1.89% |
| EBITDA Margin | -145.28% |
Management Effectiveness
| Return on Assets (ttm) | -25.83% |
| Return on Equity (ttm) | -2098.88% |
Income Statement
| Revenue (ttm) | 24.92M EUR |
| Revenue Per Share (ttm) | 1.05 EUR |
| Quarterly Revenue Growth (yoy) | 64.20% |
| Gross Profit (ttm) | 313K EUR |
| EBITDA | -36206000 EUR |
| Net Income Avi to Common (ttm) | -32050000 EUR |
| Diluted EPS (ttm) | -1.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.54M EUR |
| Total Cash Per Share (mrq) | 0.45 EUR |
| Total Debt (mrq) | 36.77M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.744 |
| Book Value Per Share (mrq) | -0.101 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -35898000 EUR |
| Levered Free Cash Flow (ttm) | -31317250 EUR |
Profile of NVN Liquidation, Inc.
| Country | Germany |
| State | NC |
| City | Durham |
| Address | 4020 Stirrup Creek Drive |
| ZIP | 27703 |
| Phone | 919 485 8080 |
| Website | https://www.novan.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 90 |
Novan, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Durham, North Carolina.
Q&A For NVN Liquidation, Inc. Stock
What is a current 6LUA.F stock price?
NVN Liquidation, Inc. 6LUA.F stock price today per share is 0.0010 EUR.
How to purchase NVN Liquidation, Inc. stock?
You can buy 6LUA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NVN Liquidation, Inc.?
The stock symbol or ticker of NVN Liquidation, Inc. is 6LUA.F.
Which industry does the NVN Liquidation, Inc. company belong to?
The NVN Liquidation, Inc. industry is Biotechnology.
How many shares does NVN Liquidation, Inc. have in circulation?
The max supply of NVN Liquidation, Inc. shares is 39.73M.
What is NVN Liquidation, Inc. Price to Earnings Ratio (PE Ratio)?
NVN Liquidation, Inc. PE Ratio is now.
What was NVN Liquidation, Inc. earnings per share over the trailing 12 months (TTM)?
NVN Liquidation, Inc. EPS is -1.18 EUR over the trailing 12 months.
Which sector does the NVN Liquidation, Inc. company belong to?
The NVN Liquidation, Inc. sector is Healthcare.